Main Article Content

Aedes (Stegomyia) aegypti is the main vector of dengue, zika and chikungunya in the Americas. These diseases have a significant impact on public health. According to the World Health Organization (WHO), controlling these diseases requires a comprehensive approach, and the control of larvae is a part of that strategy. Insect growth regulator (IGR) insecticides stand out as an efficient alternative for facilitating the control of Ae. aegypti at immature stages. The main goal was to evaluate the effectiveness of IGR novaluron 0.2 % GR, in the 50, 90, 95 and 99 lethal concentrations (LC) for fourth-instar larvae of Ae. aegypti in the laboratory. In field conditions, the percentage of inhibition of emergence was estimated by using the LC levels obtained in the laboratory through two methods of water management with refill and without refill in 40 L recipients. The study was carried out in 30 homes in a neighborhood with a high incidence of dengue in Medellin (Antioquia, Colombia). The bioassays completed indicated that LC 50, 90, 95 and 99 corresponded to 0.019, 0.055, 0.065 and 0.084 mg/L, respectively. The field results indicated that novaluron 0.2 % GR efficiently inhibited the emergence of adult Ae. aegypti, suggesting that the product has potential as a population regulator at very low concentrations. The product is considered extremely useful for programs to prevent and control dengue, zika and chikungunya.

Quimbayo F., M., Pérez-Pérez, J., Rodríguez-Gaviria, P. A., Amaya, J. D., & Rúa-Uribe, G. L. (2019). Evaluation of the efficacy of novaluron 0.2 % GR for the control of Aedes (Stegomyia) aegypti (Diptera). Revista Colombiana De Entomología, 45(1), e7812.

ÁLVAREZ, L.; BRICEÑO, A.; OVIEDO, M. 2006. Resistencia al temefos en poblaciones de Aedes aegypti (Diptera: Culicidae) del occidente de Venezuela. Revista Colombiana de Entomología 32: 172-175.

AMERICAN MOSQUITO CONTROL ASSOCIATION (AMCA). 1970. Manual for mosquito rearing and experimental techniques. Bulletin Nº 5. 112 p.

ANAYA, Y.; COCHERO, S.; REY, G.; SANTACOLOMA, L. 2007. Evaluación de la susceptibilidad a insecticidas en Aedes aegypti capturados en Sincelejo. Memorias XIII Congreso colombiano de parasitología y medicina tropical. Biomédica 27: 257.

ARREDONDO-JIMÉNEZ, J. I.; VALDEZ-DELGADO, K. M. 2006. Effect of novaluron (Rimon® 10 EC) on the mosquitoes Anopheles albimanus, Anopheles pseudopunctipennis, Aedes aegypti, Aedes albopictus and Culex quinquefasciatus from Chiapas, Mexico. Medical and Veterinary Entomology 20: 377-387.

BOOKSTEIN F. L. 1991. Morphometric tools for landmark data. Geometry and biology. Cambridge University Press.

BRAGA, I. A.; LIMA, J.; SOARES, S.; VALLE, D. 2004. Aedes aegypti resistance to temephos during 2001 in several municipalities in the states of Rio de Janeiro, Sergipe, and Alagoas, Brazil. Memórias do Instituto Oswaldo Cruz 99 (2): 199-203.

CAO-LORMEAU, V. M.; BLAKE, A.; MONS, S.; LASTÈRE, S.; ROCHE, C.; VANHOMWEGEN, J.; DUB, T. 2016. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387: 1531-1539.

CHANDA, E.; KANDYATA, A.; CHANDA, J.; BABOO, K. S. 2013. Bio-efficacy and persistence evaluation of Dimilin® GR-2 % and Mosquiron® 10 EC insect growth regulators against Anopheles gambiae s.l. (Diptera: Culicidae) larvae. Journal Biomedical Science and Engineering 6: 11-16.

CONDE, M.; ORJUELA, L.; CASTWLLANOS, C.; HERRERA-VARELA, M.; LICASTRO, S.; QUIÑONES, M. 2015. Evaluación de la sensibilidad a insecticidas en poblaciones de Aedes aegypti (Diptera: Culicidae) del departamento de Caldas, Colombia, en 2007 y 2011. Biomédica 35 (1): 43-52. doi:

CONVENIO DANE - MUNICIPIO DE MEDELLÍN. 2009. Municipio de Medellín. Proyecciones de población 2006 - 2015. Por comunas y corregimientos. Resultados Convenio Interadministrativo DANE- Municipio de Medellín, Colombia. 395 p.

FARNESI, L. C.; BRITO, J. M.; LINSS, J. G.; PELAJO-MACHADO, M.; VALLE, D. 2012 Physiological and morphological aspects of Aedes aegypti developing larvae: Effects of the chitin synthesis inhibitor novaluron. PLoS ONE 7 (1): e30363.

FINNEY D. J. 1971. Probit Analysis, 3ra ed, Cambridge University Press, Cambridge. 333 p.

FONSECA, I.; BOLAÑOS, D.; GÓMEZ, W.; QUIÑONES, M. 2007. Evaluación de la susceptibilidad de larvas de Aedes aegypti a insecticidas en el departamento de Antioquia. Memorias XIII Congreso colombiano de parasitología y medicina tropical. Biomédica 27 (2): 176.

FONTOURA, N. G.; BELLINATO, D. F.; VALLE, D.; LIMA, J. B. P. 2012. The efficacy of a chitin synthesis inhibitor against field populations of organophosphate-resistant Aedes aegypti in Brazil. Memorias do Instituto Oswaldo Cruz 107: 387-395.

FULCHER, A.; RUI-DE XUE, J. M. S.; SMITH, M. L.; GAINES, M. K.; WEAVER, J. H. 2016. Field evaluation of mosquiron 0.12 crd against Culex quinquefasciatus in storm drains, downtown St. Augustine, Florida. Technical Bulletin of the Florida Mosquito Control Association 10: 54.

GRISALES, N.; POUPARDIN, R.; GÓMEZ, S.; FONSECA-GONZÁLEZ, I.; RANSON, H.; LENHART, A. 2013. Temephos resistance in Aedes aegypti in Colombia compromises dengue vector control. PLOS Neglected Tropical Diseases 7: (e2438)

HILTON, R. J.; VANBUSKIRK, P. D. 2002. Evaluation of codling moth controls: dimilin, novaluron and avaunt. pp. 1-8. In: Proceedings of the 76th Annual Wester Orchard Pest and Disease Management Conference. 1-8. Annual Western Orchard Pest of Disease Management Conference, 2002 Washington D. C.

INSTITUTO NACIONAL DE SALUD (INS). 2014. Enfermedades transmitidas por vectores. Boletín Epidemiológico. Semana epidemiológica número 20 de 2014 (11 May. al 17 May.). Disponible en: [Fecha revisión: 19 noviembre 2016].

INSTITUTO NACIONAL DE SALUD (INS). 2016. Enfermedades transmitidas por vectores. Boletín Epidemiológico. Semana epidemiológica número 20 de 2016 (15 may. al 21 may.). Disponible en: [Fecha revisión: 19 noviembre 2016].

JARAMILLO-O, N.; DUJARDIN, J. P.; CALLE-LONDOÑO, D. A.; FONSECA-GONZÁLEZ, I. 2015. Geometric morphometrics for the taxonomy of 11 species of Anopheles (Nyssorhynchus) mosquitoes. Medical and Veterinary Entomology 29: 26-36.

JAMBULINGAM, P.; SADANANDANE, C.; NITHIYANANTHAN, N.; SUBRAMANIAN, S.; ZAIM, M. 2009. Efficacy of novaluron against Culex quinquefasciatus in smalland medium-scale trials, India. Journal of the American Mosquito Control Association 25 (3): 315-322.

KOURI, G. 2006. El dengue, un problema creciente de salud en las Américas. Revista Panamericana Salud Pública 19: 3.

LÓPEZ-GATELL, H.; ALPUCHE-ARANDA, C. M.; SANTOS-PRECIADO, J.; HERNÁNDEZ-ÁVILA, M. 2016. Dengue vaccine: local decisions, global consequences. Bulletin World Health Organization 16 (94): 850-855.

MAESTRES, R.; REY, V. G.; DE LAS SALAS, A. J.; VERGARA, S. C.; SANTACOLOMA, V. L.; GOENAGA, O. S.; CARRASQUILLA, F. M. 2009. Susceptibilidad de Aedes aegypti (Diptera: Culicidae) a temefos en Atlántico-Colombia. Revista Colombiana de Entomología 35: 202-205.

MINISTERIO DE SALUD Y PROTECCIÓN SOCIAL DE COLOMBIA (MinSalud). 2015. MinSalud confirma primeros nueve casos de zika en Colombia. Disponible en: [Fecha revisión: 27 agosto 2017].

MULLA, M. S.; DARWAZEH, H. A. 1988. Efficacy of new insect growth regulators against mosquito larvae in dairy wastewater lagoons. Journal of the American Mosquito Control Association 4 (3): 322-325.

MULLA, M. S.; THAVARA, U.; TAWATSIN, A.; CHOMPOOSRI, J.; ZAIM, M.; SU, T. 2003. Laboratory and field evaluation of novaluron, a new acylurea insect growth regulator, against Aedes aegypti (Diptera: Culicidae). Journal of Vector Ecology 28 (2): 241-254.

NASCI, R. S. 1986. Relationship between adult mosquito (Diptera: Culicidae) body size and parity in field populations. Environmental Entomology 15 (4): 874-876.

NASCI, R. S. 1987. Adult body size and parity in field populations of the mosquitoes Anopheles crucians, Aedes taeniorhynchus and Aedes sollicitans. Journal of the American Mosquito Control Association 3 (4): 636-637.

NASCI, R. S.; MITCHELL, C. J. 1994. Larval diet, adult size, and susceptibility of Aedes aegypti (Diptera: Culicidae) to infection with Ross River virus. Journal of Medical Entomology 31 (1): 123-126.

NWANKWO, E. N.; OKONKWO, N. J.; OZUMBA, N. A.; OKAFOR, E. G. 2011. Comparative studies on the larvicidal action of novaluron (Mosquiron® 100EC) and Moringa oliefera (LAM) Seed Oil against Aedes aegypti (Diptera: Culicidae) larvae. African Research Review 5 (1): 424-437.

OCAMPO, C. B.; SALAZAR-TERREROS, M. J.; MINA, N. J.; MCALLISTER, J.; BROGDON, W. 2011. Insecticide resistance status of Aedes aegypti in 10 localities in Colombia. Acta Tropica 118: 37-44.

PADILLA, J., ROJAS D.; SÁENZ-GÓMEZ, R. 2012. Dengue en Colombia: epidemiología de la reemergencia a la hiperendemia. Bogotá, Colombia. 281 p.

PANAMERICAN HEALTH ORGANIZATION (PAHO). 2008. Reports cases of dengue and dengue hemorrhagic fever (DHF), region of the Americas (by country and subregion). Washington, DC, Pan American Health Organization 78 (3): 364-369.

RAWLINS, S. C.; WAN, J. O. 1995. Resistance in some Caribbean populations of Aedes aegypti to several insecticides Journal of the American Mosquito Control Association 11: 59-65.

RINCÓN SILVA, N. G.; RINCÓN SILVA, J. D. 2016. Impacto general de las fiebres del Zika y Chikungunya en Colombia y América del Sur: Análisis general de los virus y su importancia. Biociencias. Revista de la Facultad de Ciencias de la Salud de la Universidad Libre Seccional Barranquilla 11 (2): 77-93.

RUIZ-LÓPEZ, F.; GONZÁLEZ-MAZO, A.; VELEZ-MIRA, A.; GÓMEZ, G.; ZULETA, L. 2016. Presencia de Aedes (Stegomyia) aegypti (Linneaus, 1762) y su infección natural con el virus del dengue en alturas no registradas para Colombia. Biomédica 36 (2): 303-308.

SALAZAR, M.; CARVAJAL, A.; CUELLAR, M.; OLAYA, A.; QUIÑONES, J. 2007. Resistencia a insecticidas en poblaciones de Aedes aegypti y Anopheles spp. en los departamentos de Huila, Valle, Cauca y Nariño. Memorias XIII Congreso colombiano de parasitología y medicina tropical. Biomédica 27 (2): 177.

SAN MARTIN, J. L. 2009. Dengue, guías para el diagnóstico, tratamiento prevención y control. [Monografía en internet]. Organización Mundial de la Salud (OMS) Programa especial para la investigación y capacitación de enfermedades tropicales (TDR). Disponible en: [Fecha revisión: 28 enero 2015].

SANTACOLOMA, L.; BROCHERO, H.; CHÁVEZ, B. 2007. Estado de la susceptibilidad a insecticidas de Aedes aegypti en cinco departamentos de Colombia. Memorias XIII Congreso colombiano de parasitología y medicina tropical. Biomédica 27 (2): 175.

SANTACOLOMA, L.; CHAVES, B.; BROCHERO, H. 2012. Estado de la susceptibilidad de poblaciones naturales del vector del dengue a insecticidas en trece localidades de Colombia. Biomédica 32 (3): 333-343.

SISTEMA DE INFORMACIÓN PARA LA VIGILANCIA EN SALUD PÚBLICA (SIVIGILA). 2014. Datos Sistema de Vigilancia en Salud Pública SIVIGILA 2014. Instituto Nacional de Salud, Ministerio de Salud y Protección Social, Bogotá, D. C., Colombia. Disponible en: [Fecha revisión: 30 agosto 2017].

SUÁREZ, M. F.; GONZÁLEZ, R.; MORALES, C. 1996. Temefos resistance to Aedes aegypti in Cali, Colombia. 45ª Annual meeting of the American Society of Tropical Medicine and Hygiene, 110 Baltimore, Maryland. Supplement to the American Journal of Tropical Medicine and Hygiene 55: 257.

SUMANOCHITRAPON, W.; STRICKMAN, D.; SITHIPRASASNA, R.; KITTAYAPONG, P.; INNIS, B. 1998. Effect of size and geographic origin of Aedes aegypti on oral infection with dengue-2 virus. American Journal of Tropical Medicine Hygiene 58 (3): 283-286.

TAWATSIN, A.; THAVARA, U.; BHAKDEENUAN, P.; CHOMPOOSRI, J.; SIRIYASATIEN, P.; ASAVADACHANUKORN, P.; MULLA, M. S. 2007. Field evaluation of novaluron, a chitin synthesis inhibitor larvicide, against mosquito larvae in polluted water in urban areas of Bangkok, Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 38 (3): 434-441.

WORLD HEALTH ORGANIZATION (WHO). 2005a. Guidelines for laboratory and field testing of mosquito larvicides. WHO/CDS/WHOPES/GCDPP/2005.13. WHO, Communicable Disease Control, Prevention and Eradication WHO Pesticide Evaluation Scheme 41 p.

WORLD HEALTH ORGANIZATION (WHO). 2005b. Report of the eighth WHOPES working group meeting. Review of novaluron 10 % EC. WHO/CDS/WHOPES/2005.10. Ginebra. WHO 42 p.